Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Polypeptide-chelating agent complexes reported by Novartis

Jan. 5, 1998

New photodynamic agents reported by Novartis

Dec. 31, 1997

Salagen Tablets enters phase III development in Japan

Dec. 30, 1997

Merck continues to pursue peptidomimetic farnesyltransferase inhibitors

Dec. 30, 1997

VRCTC-310: MTD, preliminary efficacy and pharmacokinetic data in humans

Dec. 29, 1997

SAR leading to new topoisomerase I inhibitor presented by Banyu

Dec. 29, 1997

Peptidomimetic protein farnesyltransferase inhibitors in development at Merck

Dec. 24, 1997

ICI-182780 associated with longer remission duration than megestrol in resistant breast cancer

Dec. 22, 1997

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

Dec. 22, 1997

Squalamine enters phase I for the treatment of cancer

Dec. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...